hotspot -WSS

hotspot

author：knowledge 2025-09-29 18:18:49 - browse：26

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Republican states more likely to report Covid vaccine side effects

WSS

Where are patients getting their prescriptions for GLP

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Covid's long

Oral obesity drug from Viking Therapeutics hits key early target

Gut bacteria may contribute to kidney autoimmunity, study finds

Alzheimer's risk factor APOE4 may be a distinct form of the disease

entertainment

hotspot

focus

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Anesthesiologist group: stop taking Ozempic before surgery

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Peter Hotez and the public health issue of online harassment

Bird flu in dairy cattle: New measures to control spread to humans

Supreme Court strikes down use of affirmative action

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

How one medical school became remarkably diverse

Young boy dies in trial for Pfizer Duchenne gene therapy

knowledge

The perfect storm of weather conditions that led to the devastating wildfires in Maui

The history of OxyContin, told through Purdue Pharma documents

Study: Black kids more likely to die after surgery than white kids

Study: Black kids more likely to die after surgery than white kids

Medicare Advantage 2025 payments will dip, Biden administration says

Scientific mystery highlights the blind spots in genomics databases

focus

knowledge

focus

explore